Evidence map›Paper›PMID 32300347›Full record

ArticleFrontiers in immunology2020

Unique Roles for

Alicia K Wooten, Anukul T Shenoy, Emad I Arafa, Hisashi Akiyama, Ian M C Martin, Matthew R Jones, Lee J Quinton, Suryaram Gummuluru, Guangchun Bai, Joseph P Mizgerd

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Loss of Pde1 function acts as an evolutionary gateway to penicillin resistance inProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Alicia K WootenPulmonary Center, Boston University School of Medicine, Boston, MA, United States.
Anukul T ShenoyPulmonary Center, Boston University School of Medicine, Boston, MA, United States.
Emad I ArafaPulmonary Center, Boston University School of Medicine, Boston, MA, United States.
Hisashi AkiyamaDepartment of Microbiology, Boston University School of Medicine, Boston, MA, United States.
Ian M C MartinPulmonary Center, Boston University School of Medicine, Boston, MA, United States.
Matthew R JonesPulmonary Center, Boston University School of Medicine, Boston, MA, United States.
Lee J QuintonPulmonary Center, Boston University School of Medicine, Boston, MA, United States.
Suryaram GummuluruDepartment of Microbiology, Boston University School of Medicine, Boston, MA, United States.
Guangchun BaiDepartment of Immunology and Microbial Disease, Albany Medical College, Albany, NY, United States.
Joseph P MizgerdPulmonary Center, Boston University School of Medicine, Boston, MA, United States.
Boston University · USAlbany Medical Center Hospital · US

Funding

BIOLOGY OF THE LUNG--MULTIDISCIPLINARY PROGRAMT32HL007035 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Darrell N. Kotton, JOSEPH P MIZGERD · 1985 to 2026
$24.3M
RESEARCH TRAINING IN IMMUNOLOGYT32AI007309 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GUMMULURU, SURYARAM · 1988 to 2024
$7.4M
Pneumonia BiologyR35HL135756 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MIZGERD, JOSEPH P · 2017 to 2023
$6.6M
Mechanism of cell-associated HIV-1 transmissionR01AI064099 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GUMMULURU, SURYARAM · 2005 to 2020
$5.9M
Lung-resident antibacterial heterotypic immunityR01AI115053 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MIZGERD, JOSEPH P · 2015 to 2023
$4.0M
The Biology of LIF During PneumoniaR01HL111449 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI QUINTON, LEE · 2012 to 2020
$3.7M
Origins and functional roles of Miwi2-positive multiciliated cells during inflammationR01HL136725 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FINE, ALAN FINE, JONES, MATTHEW ROBERT · 2018 to 2021
$1.6M
Liver-derived protection during pneumonia and sepsisR01GM120060 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI QUINTON, LEE · 2017 to 2020
$1.3M
Pneumonia and Alveolar Macrophage ResilienceF31HL147397 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ARAFA, EMAD · 2019 to 2021
$93k
NHLBI NIH HHS F31 HL147397NHLBI NIH HHS R01 HL111449NHLBI NIH HHS R01 HL136725NHLBI NIH HHS R35 HL135756NHLBI NIH HHS T32 HL007035NIAID NIH HHS R01 AI064099NIAID NIH HHS R01 AI115053NIAID NIH HHS T32 AI007309NIGMS NIH HHS R01 GM120060
6 · The paper itself

Abstract

Cyclic di-AMP (c-di-AMP) is an important signaling molecule for pneumococci, and as a uniquely prokaryotic product it can be recognized by mammalian cells as a danger signal that triggers innate immunity. Roles of c-di-AMP in directing host responses during pneumococcal infection are only beginning to be defined. We hypothesized that pneumococci with defective c-di-AMP catabolism due to phosphodiesterase deletions could illuminate roles of c-di-AMP in mediating host responses to pneumococcal infection. Pneumococci deficient in phosphodiesterase 2 (Pde2) stimulated a rapid induction of interferon β (IFNβ) expression that was exaggerated in comparison to that induced by wild type (WT) bacteria or bacteria deficient in phosphodiesterase 1. This IFNβ burst was elicited in mouse and human macrophage-like cell lines as well as in primary alveolar macrophages collected from mice with pneumococcal pneumonia. Macrophage hyperactivation by Pde2-deficient pneumococci led to rapid cell death. STING and cGAS were essential for the excessive IFNβ induction, which also required phagocytosis of bacteria and triggered the phosphorylation of IRF3 and IRF7 transcription factors. The select effects of Pde2 deletion were products of a unique role of this enzyme in c-di-AMP catabolism when pneumococci were grown on solid substrate conditions designed to enhance virulence. Because pneumococci with elevated c-di-AMP drive aberrant innate immune responses from macrophages involving hyperactivation of STING, excessive IFNβ expression, and rapid cytotoxicity, we surmise that c-di-AMP is pivotal for directing innate immunity and host-pathogen interactions during pneumococcal pneumonia.

Indexed as

AnimalsBacterial ProteinsCyclic Nucleotide Phosphodiesterases, Type 2Dinucleoside PhosphatesHost-Pathogen InteractionsHumansImmunity, InnateMacrophagesMiceMice, Inbred C57BLPneumonia, PneumococcalRAW 264.7 CellsStreptococcus pneumoniaeBacterial Proteinscyclic diadenosine phosphateCyclic Nucleotide Phosphodiesterases, Type 2Dinucleoside Phosphatescyclic di-AMPinnate immunityinterferon-βmacrophagespneumococcuspneumoniaSTING

Identifiers

PMID32300347
PMCPMC7145409
OpenAlexW3014788818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.